Logo image of NMTC

NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock Earnings & Estimates

NASDAQ:NMTC - US64130M2098 - Common Stock

0.7708 USD
-0.01 (-1.26%)
Last: 8/26/2025, 8:00:01 PM
0.7862 USD
+0.02 (+2%)
After Hours: 8/26/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
NMTC revenue by date.NMTC revenue by date.
2.12M
783.33%
3.448M
62.66%
3.453M
0.13%
8.874M
156.99%
12.648M
42.53%
17.748M
40.32%
23.491M
32.36%
EBITDA
YoY % growth
NMTC ebitda by date.NMTC ebitda by date.
-9.91M
2.27%
-11.756M
-18.63%
-11.64M
0.98%
-13.566M
-16.54%
N/AN/AN/A
EBIT
YoY % growth
NMTC ebit by date.NMTC ebit by date.
-10.03M
1.86%
-11.955M
-19.20%
-11.887M
0.57%
-5.753M
51.61%
-8.344M
-45.04%
-6.355M
23.84%
-3.703M
41.73%
Operating Margin
NMTC operating margin by date.NMTC operating margin by date.
-473.11%-346.69%-344.26%-64.83%-65.97%-35.80%-15.76%
EPS
YoY % growth
NMTC eps by date.NMTC eps by date.
-0.63
39.74%
-0.65
-3.17%
N/A
34.09%
-0.13
69.05%
-0.15
-15.38%
-0.11
26.67%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.04
62.91%
-0.04
-168.00%
-0.05
27.14%
-0.04
-36.00%
-0.03
25.00%
-0.04-0.04
20.00%
-0.02
50.00%
-0.02
33.33%
Revenue
Q2Q % growth
2.275M
742.59%
2.407M
-26.39%
2.805M
101.80%
3.519M
107.49%
3.876M
70.37%
3.458M
43.66%
3.978M
41.82%
4.927M
40.01%
5.345M
37.90%
EBITDA
Q2Q % growth
-3.06M
-19.07%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-2.254M
19.97%
-2.315M
-235.31%
-2.428M
9.42%
-1.979M
21.46%
-1.632M
27.60%
-1.969M
14.98%
-2.009M
17.23%
-1.397M
29.38%
-979.2K
40.00%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.03
70.59%
-0.050.0241.18%
Q2 2025
Q2Q % growth
-0.07
36.36%
-0.090.0223.75%
Q1 2025
Q2Q % growth
0.06
142.86%
-0.100.16158.82%
Q4 2024
Q2Q % growth
-0.11
15.38%
-0.08-0.03-34.80%
Q3 2024
Q2Q % growth

49.00%
-0.10%
Q2 2024
Q2Q % growth
-0.11
47.62%
-0.10-0.01-7.84%
Q1 2024
Q2Q % growth
-0.14
-27.27%
-0.140.001.96%
Q4 2023
Q2Q % growth
-0.13
-44.44%
-0.180.0527.17%
Q3 2023
Q2Q % growth
-0.20
-17.65%
-0.210.014.35%
Q2 2023
Q2Q % growth
-0.21
-10.53%
-0.210.00-0.43%
Q1 2023
Q2Q % growth
-0.11
38.89%
-0.110.001.96%
Q4 2022
Q2Q % growth
-0.09
59.09%
-0.110.0219.79%
Q3 2022
Q2Q % growth
-0.17
32.00%
-0.230.0625.93%
Q2 2022
Q2Q % growth
-0.19 -0.200.016.86%
Q1 2022
Q2Q % growth
-0.18 -0.190.014.61%
Q4 2021
Q2Q % growth
-0.22 -0.220.001.96%
NMTC Yearly EPS VS EstimatesNMTC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
1.696M
105.38%
1.856M-160K-8.62%
Q2 2025
Q2Q % growth
1.39M
0.72%
2.448M-1.058M-43.22%
Q1 2025
Q2Q % growth
3.27M
234.48%
2.142M1.128M52.66%
Q4 2024
Q2Q % growth
270K
-65.50%
2.346M-2.076M-88.49%
Q3 2024
Q2Q % growth
825.8K
31.08%
2.04M-1.214M-59.52%
Q2 2024
Q2Q % growth
1.38M
196.14%
1.734M-354K-20.42%
Q1 2024
Q2Q % growth
977.65K
-37.73%
869.04K108.61K12.50%
Q4 2023
Q2Q % growth
782.52K
-61.07%
816K-33.48K-4.10%
Q3 2023
Q2Q % growth
630K
2,000.00%
357K273K76.47%
Q2 2023
Q2Q % growth
466K
1,065.00%
255K211K82.75%
Q1 2023
Q2Q % growth
1.57M
3,825.00%
1.938M-368K-18.99%
Q4 2022
Q2Q % growth
2.01M
3,920.00%
3.672M-1.662M-45.26%
Q3 2022
Q2Q % growth
30K
-50.00%
30K%
Q2 2022
Q2Q % growth
40K 40K%
Q1 2022
Q2Q % growth
40K
-55.56%
40K%
Q4 2021
Q2Q % growth
50K
-97.41%
102K-52K-50.98%
NMTC Yearly Revenue VS EstimatesNMTC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 5M 10M 15M 20M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 7.14%
Revenue0% 17.39% -0.11% -34.59%